<DOC>
	<DOCNO>NCT01526408</DOCNO>
	<brief_summary>The specific aim study determine efficacy treatment famciclovir unilateral Meniere 's Disease patient , specifically whether hear improve . The investigator determine percentage unilateral Meniere 's Disease patient experience absence hear fluctuation 3 month treatment famciclovir compare placebo arm .</brief_summary>
	<brief_title>Famvir Treatment Hearing Unilateral Meniere 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Meniere Disease</mesh_term>
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>Unilateral Meniere 's Disease 2 vertigo episode least 20 minute Fluctuating hear subjective history and/or audiometric documentation . Audiometric documentation define affected ear puretone average change audiogram Time 1 Time 2 ( less one year apart ) great 15 dB . Less 45 dB 4frequency puretone average affect ear Tinnitus and/or aural fullness Willing undergo clinical trial procedure Signed informed consent Acute chronic middle ear disease either ear Only hear ear 4frequency puretone average &gt; 45 dB either ear Known allergy famciclovir ingredient formulation Taking oral steroid receive IT steroids time enrollment . If subject oral steroids/IT steroid , 3 month must elapse last dose start treatment study Must previous inner ear surgery History immunodeficiency diseases HIV History renal insufficiency kidney diseases A female childbearing potential pregnant History noncompliance medical regimen Unwilling unable comply protocol , include schedule study evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Meniere 's Disease</keyword>
	<keyword>Vertigo</keyword>
	<keyword>Hearing loss</keyword>
	<keyword>Tinnitus</keyword>
	<keyword>Anti-viral</keyword>
	<keyword>Famciclovir</keyword>
</DOC>